Skip to content
10-K

Annual Report

SBC Medical Group Holdings Incorporated SBC SBCWW

0001193125-26-127557

← back to feed
Filed
Mar 27, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 28, 2026 102.58M sh
Shares Diluted FY 2025 · Dec 31, 2025 103M sh
Shares Diluted FY 2025 · Dec 31, 2024 96.56M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $5M
Stock Repurchased FY 2025 · Dec 31, 2024 $0
Capex FY 2025 · Dec 31, 2025 $1.4M
Capex FY 2025 · Dec 31, 2024 $2.56M
Operating Cash Flow FY 2025 · Dec 31, 2025 $24.67M
Operating Cash Flow FY 2025 · Dec 31, 2024 $20.58M
Long Term Debt FY 2025 · Dec 31, 2025 $42.83M
Short Term Investments FY 2025 · Dec 31, 2025 $319.19K
Short Term Investments FY 2025 · Dec 31, 2024 $0
Cash And Equivalents FY 2025 · Dec 31, 2025 $163.77M
Cash And Equivalents FY 2025 · Dec 31, 2024 $125.04M
Stockholders Equity FY 2025 · Dec 31, 2025 $248.28M
Stockholders Equity FY 2025 · Dec 31, 2024 $195.11M
Current Liabilities FY 2025 · Dec 31, 2025 $61.12M
Current Liabilities FY 2025 · Dec 31, 2024 $61.19M
Total Liabilities FY 2025 · Dec 31, 2025 $117.14M
Total Liabilities FY 2025 · Dec 31, 2024 $71.06M
Current Assets FY 2025 · Dec 31, 2025 $231.22M
Current Assets FY 2025 · Dec 31, 2024 $184.45M
Total Assets FY 2025 · Dec 31, 2025 $380.45M
Total Assets FY 2025 · Dec 31, 2024 $266.08M
Eps Diluted FY 2025 · Dec 31, 2025 $0.50
Eps Diluted FY 2025 · Dec 31, 2024 $0.48
Eps Basic FY 2025 · Dec 31, 2025 $0.50
Eps Basic FY 2025 · Dec 31, 2024 $0.48
Sga Expense FY 2025 · Dec 31, 2025 $59.8M
Sga Expense FY 2025 · Dec 31, 2024 $57.67M
Net Income FY 2025 · Dec 31, 2025 $50.99M
Net Income FY 2025 · Dec 31, 2024 $46.61M
Operating Income FY 2025 · Dec 31, 2025 $67.49M
Operating Income FY 2025 · Dec 31, 2024 $70.3M
Gross Profit FY 2025 · Dec 31, 2025 $127.28M
Gross Profit FY 2025 · Dec 31, 2024 $156.05M
Cost Of Revenue FY 2025 · Dec 31, 2025 $46.32M
Cost Of Revenue FY 2025 · Dec 31, 2024 $49.37M
Revenue FY 2025 · Dec 31, 2025 $173.61M
Revenue FY 2025 · Dec 31, 2024 $205.42M